CB2 Named one of Three Ancillary Cannabis Companies Aggressively Scaling Their Footprint

Merida portfolio company CB2 Insights (CBII.CN) is one of the ancillary cannabis companies highlighted by Technical420 as a favorable opportunity capitalizing on underserved markets within the cannabis industry while not actually touching the plant. recently commenced trading on the Canadian Stock Exchange and is a company that is on our radar. CB2 represents a differentiated opportunity and is a medical clinic and data company that has three business lines:

You can read the full Technical420 post here.